Companies Dominating the Chronic Wound Care Landscape
- Smith & Nephew PLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ölnlycke Health Care AB
- ConvaTec, Inc.
- Integra LifeSciences Corporation
- Coloplast A/S
- Cardinal Health, Inc.
- Tissue Regenix Ltd
- B. Braun Melsungen AG
- MIMEDX, Inc.
- 3M
Browse Key Market Insights with Data Illustration:
In the News
-
Smith & Nephew PLC has announced the efficiency of its GRAFIX Membrane which reduces diabetic foot ulcer recurrence by half as compared to other leading competitors.
-
Integra LifeSciences Corporation announced the positive clinical outcomes with its PriMatrix Dermal Repair Scaffold for the treatment of hard-to-heal diabetic foot ulcers (DFUs). This is the largest DFU RCT ever conducted. A per protocol analysis found that 60% of DFUs healed within 12 weeks when PriMatrix was used in conjunction with standard care (SOC), compared to 35% for DFUs that healed within 12 weeks when SOC was used.
